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Abstract 
This paper estimates the probability of virtual crossmatch failure in kidney exchange matching. In particu-
lar, the probability of a positive crossmatch after a negative virtual crossmatch is related to the recipient’s 
PRA level. Using Dutch kidney exchange data, we find significant evidence that this probability increases 
non-linearly with PRA level. We estimate a probit model that describes this relationship.  
 
Introduction 
Living donor kidney transplantation is the preferred treatment for patients with end-stage renal disease. 
However, due to blood type and crossmatch incompatibility over 40 percent of living donors are incompat-
ible with their intended recipient. Kidney exchange identifies matches between such incompatible donor-
recipient pairs that allow them to proceed with transplantation through a cyclic transplant procedure (1) (2) 
(3) (4) (5) (6) (7) (8). In order to determine these matches, compatibility between all patients and donors is 
usually analyzed by testing blood type compatibility and by performing a virtual crossmatch. Then, after a 
set of desirable transplant procedures is identified by a specialized computer algorithm, actual cross-
matches are performed for all selected recipient-donor combinations. If any of the actual crossmatches is 
positive, the computer algorithm is rerun with the updated compatibility structure, and the process is re-
peated until a feasible set of transplants is established. 
The number of positive crossmatches after a negative virtual crossmatch can be substantial, with figures 
up to 90 % of the performed crossmatches being reported in the US. In this research we estimate the 
probability of positive crossmatch after a negative virtual crossmatch on an individual level, using Dutch 
clinical data. In particular, we relate the probability to the recipient’s sensitization level as captured in the 
recipient’s PRA score with respect to the kidney exchange donor population. 
 
Methods 
Data 
This study uses empirical data from the registry of the Dutch national kidney exchange program. The 
available data include 438 ABO blood type or crossmatch incompatible patient-donor pairs who participat-
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ed in Dutch kidney exchanges between October 2003 and January 2011, as well as outcomes of 331 
crossmatch tests performed by the national reference laboratory for histocompatibility testing in Leiden. 
The data contain blood types of all patients and donors as well as center-reported patient PRA values at 
time of entry and, if available, at time of transplantation. Donor HLA types and recipient unacceptable HLA 
mismatches are also included. The national reference laboratory identifies unacceptable HLA specificities 
on basis of a combination of a complement dependent cytotoxicity (CDC) and a solid phase antibody 
screening. Antibody specificities leading to a positive CDC crossmatch are considered to be a contraindi-
cation for transplantation and the HLA antigens recognized are defined as unacceptable mismatches.  
 
Kidney exchange donor population based PRA levels 
Because center-reported PRA levels are based on the general population, they may not accurately reflect 
the difficulty of finding compatible donors in the kidney exchange program. For that reason additional kid-
ney exchange donor population PRA levels are computed based on virtual crossmatches between each 
patient and all donors in the data set. Throughout the rest of this paper, whenever we refer to a PRA level, 
we refer to these kidney exchange donor population based PRA levels. Table 1 details the patient and 
donor characteristics. 
 
Table 1: Patient and donor characteristics 
 ABO blood type 
 A B AB O 
Patients (%) 30 15 1 54 
Donors (%) 56 14 2 29 
 PRA level w.r.t. general population (at time of entry)  
 0-9 10-79 80-100  
Patients (%) 78 17 5  
 PRA level w.r.t. kidney exchange donor population 
 0-9 10-79 80-100  
Patients (%) 48 35 17  
 
 
Relating the probability of positive crossmatch to PRA level 
Table 2 displays the number of positive crossmatch outcomes for each of the PRA level categories of Ta-
ble 1. The numbers clearly indicate that there is a relationship between the probability of a positive cross-
match after a negative virtual crossmatch and the PRA level. 
 
Table 2: Relation between positive crossmatch and PRA level 
 PRA level w.r.t. kidney exchange donor population  
 0-9 10-79 80-100  
# Crossmatches 126 173 32  
Positive (%) 6 31 44  
 
 
3 
 
However, the crossmatch tests reported in Table 2 are not all independent. Regularly, multiple crossmatch 
tests correspond to an individual patient. Multiple tests might, for example, be required when a patient’s 
initial test is positive, or when a patient’s crossmatch test is negative but the proposed transplant proce-
dure cannot take place because of a positive crossmatch for another patient involved in the procedure. 
We need to investigate the effects and significance of this dependence relation before making inferences. 
 
Pearson’s    test for independence 
Let      denote the outcome of the  -th crossmatch test for recipient  , that is        if the crossmatch is 
positive, and         otherwise. Furthermore, let      denote recipient  ’s PRA level. We are interested in 
estimating  
                              
In order to assess whether the tests               significantly affect this probability, we perform a test of 
independence using Pearson’s    test statistic. Let     
  ∑         and     
  ∑           denote the ob-
served number of patients in PRA category   with, respectively, a positive and a negative  -th test. If there 
are a total of   observations, at most   tests per recipient, and   PRA categories, then, under the null hy-
pothesis of statistical independence, we have 
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The test statistic is then given by 
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and follows a   -distribution with     degrees of freedom.  
 
Probit regression 
In order to estimate the probability of positive crossmatch after a negative virtual crossmatch on an indi-
vidual level, we use a probit regression model. In this approach, the probabilities are modeled as 
              
    
where   ,        , denotes the  -th observed crossmatch test,   is a vector of   regressors,   is a vec-
tor of regression parameters and   is the cumulative distribution function (CDF) of the standard normal 
distribution. The parameters   are estimated by the maximum likelihood estimator  ̂ as follows: 
 ̂        {  (      )} 
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where   (      ) is the log-likelihood function defined by 
  (      )  ∑ (        
            (      
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To diagnose the quality of the regression, we perform several tests. The first is the likelihood-ratio test, 
which tests if the deviance statistic  , as defined below, deviates significantly from zero: 
       (
 ( ̂  )
 (  ̂  )
) 
where   is a vector of ones, and   ̂        {  (       )}.   follows a  
 -distribution with     degrees 
of freedom and if it differs significantly from zero, it indicates a good fit of the model. 
The next statistic for determining goodness of fit is McFadden’s   , which is computed as 
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and lies between 0 and 1. Higher values of    correspond to a relatively higher overall significance of the 
model. 
Finally, we perform a Lagrange Multiplier (LM) test on heteroskedasticity of the form  
                  
               
with 
    
  
   
where    is a vector of observed variables, and   is a vector of regression parameters. The LM test is per-
formed by taking the standardized residuals   
  from the homoskedastic model, regressing these on the 
gradient of the heteroskedastic model using ordinary least squares, and then computing 
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where    ̂ denote the fitted values of the secondary regression. Under the null hypothesis of homoskedas-
ticity,          where   is the number of parameters in  . 
 
 
 
Results 
Table 3 shows the outcomes of a    test for independence of the probability of a positive crossmatch test 
and the outcomes of previous tests, per PRA category as in Table 1. For each of the PRA categories, 
there is no significant evidence to reject the null hypothesis of independence. Therefore all the observed 
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crossmatch results can be straightforwardly used to estimate the probability of a positive crossmatch with-
in each PRA category, as was done in Table 2. 
 
Table 3: Test for independence 
  Test 1 Test 2 Test 3 Test 4 Test 5 Test 6 Test 7 Total 
PRA 0-9 Positives 4 2 1 0    7 
 Negatives 79 31 8 1    119 
 Total 83 33 9 1    126 
          
    = 0.69  P = 0.124       
PRA 10-79 Positives 23 16 8 3 2 1 0 53 
 Negatives 66 26 17 4 3 2 2 120 
 Total 89 42 25 7 5 3 2 173 
          
    = 3.67  P = 0.280       
PRA 80-100 Positives 8 3 2 1 0   14 
 Negatives 11 5 1 0 1   18 
 Total 19 8 3 1 1   32 
          
    = 2.85  P = 0.417       
          
 
Table 4 shows the outcomes of a probit regression of the latent individual probability of a positive cross-
match on PRA. The coefficient of PRA is highly significant, as is the likelihood-ratio test for model fit. Fig-
ure 1 shows a plot of the fitted probabilities. The non-linear relationship between the probability of a posi-
tive crossmatch and the PRA level is clearly visible. To assess whether this relationship is correctly mod-
eled, we further diagnose a plot of the standardized residuals (Figure 2). The standardized residuals be-
have nicely overall, showing only weak signs of heteroskedasticity for PRA values close to 0 and 100. This 
indicates that possibly the tails of the normal distribution do not correctly fit the distribution of the probabili-
ties. However, a formal Lagrange Multiplier test reveals that the amount of heteroskedasticity is not signifi-
cant (Table 4). It therefore appears that  
                                       
appropriately models the individual probability of a positive crossmatch. 
 
Table 4: Probit regression 
Variable Coefficient Std. Error t-Statistic Prob. 
C -1.5007 0.1486 -10.1007 <0.0001 
PRA 0.0170 0.0026 6.5340 <0.0001 
Deviance 304.5770  Prob (Deviance) <0.0001 
LM-test  1.7514  Prob (LM-test) 0.1857 
McFadden’s R-squared 0.1342    
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Figure 1 Fitted probabilities 
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Figure 2 Standardized residuals versus PRA 
Discussion 
In this paper we have estimated the probability of virtual crossmatch failure in kidney exchange matching 
by relating this probability to the recipient’s PRA level. Our findings indicate that the non-linear relationship 
between the PRA level and the probability of virtual crossmatch failure is modeled appropriately by a ho-
moskedastic probit model.  
Although this model improves on the estimations made in previous literature (e.g. (9)), we do not claim 
that the PRA level is the sole explanatory factor for virtual crossmatch failures, nor that virtual crossmatch 
failure is the only cause of failure preventing kidney exchange matches from going forward to transplanta-
tion. There may be other factors which play a role, such as recipient health status and likelihood of with-
drawal of incompatible donors, but their impact will likely be smaller than the impact of the PRA level, and 
as we did not have data available on these other factors, they were not explicitly included in this research. 
Instead, these exogenous factors are captured by the constant terms in our model.  
Additionally, our findings are conditional to our assumptions (although we applied multiple statistical test to 
verify these assumptions) and to our data (although comparison of our data (see Table 3) with the data 
used in related literature (see Table 2 in (9)) suggests failure rates are comparable).  
Considering the practical impact of failure of kidney exchange matches, particularly due to failure of virtual 
crossmatching, we hope the present paper may serve to improve kidney exchange simulations by taking 
into account virtual crossmatch failure more accurately, and thereby help policy makers select the best 
kidney exchange mechanisms. 
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